Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000817905 | SCV000958490 | uncertain significance | MHC class II deficiency | 2022-06-09 | criteria provided, single submitter | clinical testing | Variants that disrupt the consensus splice site are a relatively common cause of aberrant splicing (PMID: 17576681, 9536098). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. ClinVar contains an entry for this variant (Variation ID: 660657). This variant has not been reported in the literature in individuals affected with RFXANK-related conditions. This variant is present in population databases (rs749058206, gnomAD 0.002%). This sequence change falls in intron 6 of the RFXANK gene. It does not directly change the encoded amino acid sequence of the RFXANK protein. It affects a nucleotide within the consensus splice site. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |